glp-1 thyroid cancer risk Schematic overview of the benefits and risks associated with GLP-1s in Oncology: Exploring Risks

Food and Drug Administration (FDA) has approved four GLP-1 drugs for weight loss in people with overweight or obesity: liraglutide (Saxenda) orforglipron (Foundayo) semaglutide (Wegovy) tirzepatide (Zepound) Liraglutide, semaglutide, and tirzepatide are injectable medications that come in prefilled pens

Overcome portion control & late-night snacking with ease

Some patients with very low ferritin benefit from intravenous iron infusions, which can replete stores much more quickly

Patients should be extremely cautious of any websites, social media advertisements, or online retailers claiming to sell GLP-1 patches

What is GLP-1 and how does it affect appetite and metabolism

Retatrutide produced greater mean weight loss than tirzepatide in their respective Phase 2 obesity trials